Abstract
Objective To determine whether directly observed prostate-specific antigen (PSA) promoter diploid haplotype, either alone or in conjunction with androgen receptor (AR) genotype, is associated with prostate cancer risk.
Methods We conducted a case–control study nested within the US population-based Cardiovascular Health Study cohort. Incident prostate cancers were identified by linkage to cancer registry records for the years 1989–2000. We genotyped 193 cases and 391 controls for the PSA −252 G/A and −158 G/A SNPs and the AR CAG microsatellite, and developed methods to directly determine proximal PSA promoter haplotypes. Exact logistic regression was used to estimate odds ratios and significance levels.
Results No significant associations were observed between PSA diplotype and prostate cancer overall. Short (<20) AR CAG repeat lengths were associated with modest increases in the risk of prostate cancer (OR, 1.46; 95% CI, 0.97–2.19; p = 0.071) that were significant for advanced disease (OR, 1.82; 95% CI, 1.02–3.26; p = 0.044). Men who possessed two copies of the PSA*2 (−252G/−158G) haplotype and short AR CAG repeat lengths had a 4-fold (95% CI, 1.05–20.75; exact p = 0.040) increased risk of prostate cancer, and a 7-fold (95% CI, 1.25–39.78; exact p = 0.026) increased risk of advanced disease.
Conclusions We found evidence that the PSA*2*2 diplotype in combination with short AR CAG alleles increases a man’s risk of developing prostate cancer. These findings support an etiologic role in prostate cancer of genetic interactions between polymorphisms that increase AR transactivation strength and those that alter the regulatory regions of target genes such as PSA that are responsive to androgen stimulation.
Similar content being viewed by others
References
GD Steinberg BS Carter TH Beaty B Childs PC Walsh (1990) ArticleTitleFamily history and the risk of prostate cancer Prostate 17 337–347 Occurrence Handle1:STN:280:By6D28jlvVM%3D Occurrence Handle2251225
BS Carter TH Beaty GD Steinberg B Childs PC Walsh (1992) ArticleTitleMendelian inheritance of familial prostate cancer Proc Natl Acad Sci USA 89 3367–3371 Occurrence Handle1:STN:280:By2B38fnvVI%3D Occurrence Handle1565627
A Edwards HA Hammond L Jin CT Caskey R Chakraborty (1992) ArticleTitleGenetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups Genomics 12 241–253 Occurrence Handle10.1016/0888-7543(92)90371-X Occurrence Handle1:CAS:528:DyaK38XktVajsLg%3D Occurrence Handle1740333
NL Chamberlain ED Driver RL Miesfeld (1994) ArticleTitleThe length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function Nucleic Acids Res 22 3181–3186 Occurrence Handle1:CAS:528:DyaK2cXlvFOns7o%3D Occurrence Handle8065934
P Kazemi-Esfarjani MA Trifiro L Pinsky (1995) ArticleTitleEvidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies Hum Mol Genet 4 523–527 Occurrence Handle1:CAS:528:DyaK2MXltlSjtbg%3D Occurrence Handle7633399
RA Irvine MC Yu RK Ross GA Coetzee (1995) ArticleTitleThe CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer Cancer Res 55 1937–1940 Occurrence Handle1:CAS:528:DyaK2MXltlSgt7s%3D Occurrence Handle7728763
KA Nelson JS Witte (2002) ArticleTitleAndrogen receptor CAG repeats and prostate cancer Am J Epidemiol 155 883–890 Occurrence Handle10.1093/aje/155.10.883 Occurrence Handle11994226
P Cohen DM Peehl HC Graves RG Rosenfeld (1994) ArticleTitleBiological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease J Endocrinol 142 407–415 Occurrence Handle1:CAS:528:DyaK2cXlvFKrs7Y%3D Occurrence Handle7525824
A Grimberg P Cohen (2000) ArticleTitleRole of insulin-like growth factors and their binding proteins in growth control and carcinogenesis J Cell Physiol 183 1–9 Occurrence Handle10.1002/(SICI)1097-4652(200004)183:1<1::AID-JCP1>3.0.CO;2-J Occurrence Handle1:CAS:528:DC%2BD3cXhslWqtr8%3D Occurrence Handle10699960
CS Killian DA Corral E Kawinski RI Constantine (1993) ArticleTitleMitogenic response of osteoblast cells to prostate-specific antigen suggests an activation of latent TGF-beta and a proteolytic modulation of cell adhesion receptors Biochem Biophys Res Commun 192 940–947 Occurrence Handle10.1006/bbrc.1993.1506 Occurrence Handle1:CAS:528:DyaK3sXktVKisr8%3D Occurrence Handle7683467
SD Cramer Z Chen DM Peehl (1996) ArticleTitleProstate specific antigen cleaves parathyroid hormone-related protein in the PTH-like domain: inactivation of PTHrP-stimulated cAMP accumulation in mouse osteoblasts J Urol 156 526–531 Occurrence Handle10.1016/S0022-5347(01)65919-6 Occurrence Handle1:CAS:528:DyaK28XkvFartLs%3D Occurrence Handle8683730
PH Riegman RJ Vlietstra JA Korput Particlevan der AO Brinkmann J Trapman (1991) ArticleTitleThe promoter of the prostate-specific antigen gene contains a functional androgen responsive element Mol Endocrinol 5 1921–1930 Occurrence Handle1:CAS:528:DyaK38Xit12murs%3D Occurrence Handle1724287
KB Cleutjens CC Eekelen Particlevan HA Korput Particlevan der AO Brinkmann J Trapman (1996) ArticleTitleTwo androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter J Biol Chem 271 6379–6388 Occurrence Handle1:CAS:528:DyaK28XhslGgurc%3D Occurrence Handle8626436
KB Cleutjens HA Korput Particlevan der CC van Eekelen HC Rooij Particlevan PW Faber J Trapman (1997) ArticleTitleAn androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter Mol Endocrinol 11 148–161 Occurrence Handle1:CAS:528:DyaK2sXpsVGmuw%3D%3D Occurrence Handle9013762
Huang W, Shostak Y, Tarr P, Sawyers C, Carey M (1999) Cooperative assembly of androgen receptor into a nucleoprotein complex that regulates the prostate-specific antigen enhancer. J Biol Chem 274:25,756–25,768
A Rao SD Cramer (1999) ArticleTitleIdentification of a polymorphism in the ARE I region of the PSA promoter van Proc Am Assoc Cancer Res 40 65
QF Yang T Sakurai L Shan et al. (2000) ArticleTitleNovel polymorphisms of prostate-specific antigen (PSA) gene associated with PSA mRNA expression in breast cancer J Hum Genet 45 363–366 Occurrence Handle1:CAS:528:DC%2BD3cXos1yjsLw%3D Occurrence Handle11185746
WM Xue GA Coetzee RK Ross et al. (2001) ArticleTitleGenetic determinants of serum prostate-specific antigen levels in healthy men from a multiethnic cohort Cancer Epidemiol Biomarkers Prev 10 575–579 Occurrence Handle1:CAS:528:DC%2BD3MXlt1SrtrY%3D Occurrence Handle11401905
W Xue RA Irvine MC Yu RK Ross GA Coetzee SA Ingles (2000) ArticleTitleSusceptibility to prostate cancer: interaction between genotypes at the androgen receptor and prostate-specific antigen loci Cancer Res 60 839–841 Occurrence Handle1:CAS:528:DC%2BD3cXhs1Siu74%3D Occurrence Handle10706090
Q Yang L Shan N Segawa et al. (2001) ArticleTitleNovel polymorphisms in prostate specific antigen gene and its association with prostate cancer Anticancer Res 21 197–200 Occurrence Handle1:CAS:528:DC%2BD3MXivFCmsro%3D Occurrence Handle11299734
J Akey L Jin M Xiong (2001) ArticleTitleHaplotypes vs single marker linkage disequilibrium tests: what do we gain? Eur J Hum Genet 9 291–300 Occurrence Handle10.1038/sj.ejhg.5200619 Occurrence Handle1:CAS:528:DC%2BD3MXjsVWgsb4%3D Occurrence Handle11313774
PM McKeigue (2000) ArticleTitleEfficiency of estimation of haplotype frequencies: use of marker phenotypes of unrelated individuals versus counting of phase-known gametes Am J Hum Genet 67 1626–1627 Occurrence Handle10.1086/316912 Occurrence Handle1:STN:280:DC%2BD3M%2Fos1Wnsg%3D%3D Occurrence Handle11078483
JA Douglas M Boehnke E Gillanders JM Trent SB Gruber (2001) ArticleTitleExperimentally-derived haplotypes substantially increase the efficiency of linkage disequilibrium studies Nat Genet 28 361–364 Occurrence Handle10.1038/ng582 Occurrence Handle1:CAS:528:DC%2BD3MXlslejsbo%3D Occurrence Handle11443299
LP Fried NO Borhani P Enright et al. (1991) ArticleTitleThe cardiovascular health study: design and rationale Ann Epidemiol 1 263–276 Occurrence Handle1:STN:280:ByuD1MznsFY%3D Occurrence Handle1669507
Bergstralh EJ, Kosanke JL, (1995) Computerized matching of controls. Technical Report Series No. 56. Department of Health Science Research, Mayo Clinic, Rochester, MN
E Giovannucci MJ Stampfer K Krithivas et al. (1997) ArticleTitleThe CAG repeat within the androgen receptor gene and its relationship to prostate cancer Proc Natl Acad Sci USA 94 3320–3323 Occurrence Handle10.1073/pnas.94.7.3320 Occurrence Handle1:CAS:528:DyaK2sXisVKgu7Y%3D Occurrence Handle9096391
Young JLJ, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA, eds (2001) SEER Summary Staging Manual – 2000: Codes and Coding Instructions. National Cancer Institute, Bethesda, MD
Fritz A, Ries L, eds (1998) The SEER Program Code Manual. 3rd edn. National Cancer Institute, Bethesda, MD
PW Kantoff (2002) Prostate cancer DC Dale DD Federman (Eds) Scientific American Medicine Scientific American New York, NY
BS Weir (1996) Genetic Data Analysis II Sinauer Associates Sunderland, MA
RC Lewontin (1964) ArticleTitleThe interaction of selection and linkage. I. General considerations; heterotic models Genetics 49 49–67
CR Mehta NR Patel P Senchaudhuri (2000) ArticleTitleEfficient Monte Carlo methods for conditional logistic regression J Am Stat Assoc 95 99–108
SA Ingles RK Ross MC Yu et al. (1997) ArticleTitleAssociation of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor J Natl Cancer Inst 89 166–170 Occurrence Handle10.1093/jnci/89.2.166 Occurrence Handle1:STN:280:ByiC2M3isFA%3D Occurrence Handle8998186
DM Peehl (1995) ArticleTitleProstate specific antigen role and function Cancer 75 2021–2026
CH Chiang KK Chen LS Chang CJ Hong (2004) ArticleTitleThe impact of polymorphism on prostate specific antigen gene on the risk, tumor volume and pathological stage of prostate cancer J Urol 171 1529–1532 Occurrence Handle10.1097/01.ju.0000116538.15995.93 Occurrence Handle1:CAS:528:DC%2BD2cXjtFWgs7w%3D Occurrence Handle15017213
A Gsur M Preyer G Haidinger et al. (2002) ArticleTitlePolymorphic CAG repeats in the androgen receptor gene, prostate-specific antigen polymorphism and prostate cancer risk Carcinogenesis 23 1647–1651 Occurrence Handle10.1093/carcin/23.10.1647 Occurrence Handle1:CAS:528:DC%2BD38XnvF2qsL8%3D Occurrence Handle12376473
R Medeiros A Morais A Vasconcelos et al. (2002) ArticleTitleLinkage between polymorphisms in the prostate specific antigen ARE1 gene region, prostate cancer risk, and circulating tumor cells Prostate 53 88–94 Occurrence Handle10.1002/pros.10135 Occurrence Handle1:CAS:528:DC%2BD38Xns1amtb0%3D Occurrence Handle12210484
LZ Wang K Sato N Tsuchiya et al. (2003) ArticleTitlePolymorphisms in prostate-specific antigen (PSA) gene, risk of prostate cancer, and serum PSA levels in Japanese population Cancer Lett 202 53–59 Occurrence Handle10.1016/j.canlet.2003.08.001 Occurrence Handle1:CAS:528:DC%2BD3sXpt1elurY%3D Occurrence Handle14643026
JL Stanford JJ Just M Gibbs et al. (1997) ArticleTitlePolymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk Cancer Res 57 1194–1198 Occurrence Handle1:CAS:528:DyaK2sXhvFOitr4%3D Occurrence Handle9067292
AW Hsing YT Gao G Wu et al. (2000) ArticleTitlePolymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case–control study in China Cancer Res 60 5111–5116 Occurrence Handle1:CAS:528:DC%2BD3cXntVamtbg%3D Occurrence Handle11016637
VR Panz BI Joffe I Spitz T Lindenberg A Farkas M Haffejee (2001) ArticleTitleTandem CAG repeats of the androgen receptor gene and prostate cancer risk in black and white men Endocrine 15 213–216 Occurrence Handle10.1385/ENDO:15:2:213 Occurrence Handle1:CAS:528:DC%2BD3MXotVSrtbg%3D Occurrence Handle11720249
F Modugno JL Weissfeld DL Trump et al. (2001) ArticleTitleAllelic variants of aromatase and the androgen and estrogen receptors: toward a multigenic model of prostate cancer risk Clin Cancer Res 7 3092–3096 Occurrence Handle1:CAS:528:DC%2BD3MXnvF2ku70%3D Occurrence Handle11595700
I Balic ST Graham DA Troyer et al. (2002) ArticleTitleAndrogen receptor length polymorphism associated with prostate cancer risk in Hispanic men J Urol 168 2245–2248 Occurrence Handle10.1016/S0022-5347(05)64364-9 Occurrence Handle1:CAS:528:DC%2BD38XotFKrtrY%3D Occurrence Handle12394768
N Mononen T Ikonen V Autio et al. (2002) ArticleTitleAndrogen receptor CAG polymorphism and prostate cancer risk Hum Genet 111 166–171 Occurrence Handle10.1007/s00439-002-0776-5 Occurrence Handle1:CAS:528:DC%2BD38Xmt1Wis70%3D Occurrence Handle12189490
SM Edwards MD Badzioch R Minter et al. (1999) ArticleTitleAndrogen receptor polymorphisms: association with prostate cancer risk, relapse and overall survival Int J Cancer 84 458–465 Occurrence Handle10.1002/(SICI)1097-0215(19991022)84:5<458::AID-IJC2>3.0.CO;2-Y Occurrence Handle1:CAS:528:DyaK1MXmslGhsL8%3D Occurrence Handle10502720
O Bratt A Borg U Kristoffersson R Lundgren QX Zhang H Olsson (1999) ArticleTitleCAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk Br J Cancer 81 672–676 Occurrence Handle10.1038/sj.bjc.6690746 Occurrence Handle1:CAS:528:DyaK1MXntVSquro%3D Occurrence Handle10574254
L Correa-Cerro G Wohr J Haussler et al. (1999) ArticleTitle(CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French–German population Eur J Hum Genet 7 357–362 Occurrence Handle10.1038/sj.ejhg.5200298 Occurrence Handle1:STN:280:DyaK1M3ltVOksw%3D%3D Occurrence Handle10234512
EA Miller JL Stanford L Hsu E Noonan EA Ostrander (2001) ArticleTitlePolymorphic repeats in the androgen receptor gene in high-risk sibships Prostate 48 200–205 Occurrence Handle10.1002/pros.1098 Occurrence Handle1:CAS:528:DC%2BD3MXmsVynur0%3D Occurrence Handle11494335
AG Latil R Azzouzi GS Cancel et al. (2001) ArticleTitleProstate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways Cancer 92 1130–1137 Occurrence Handle10.1002/1097-0142(20010901)92:5<1130::AID-CNCR1430>3.0.CO;2-B Occurrence Handle1:CAS:528:DC%2BD3MXnt12mur8%3D Occurrence Handle11571725
J Beilin L Harewood M Frydenberg et al. (2001) ArticleTitleA case–control study of the androgen receptor gene CAG repeat polymorphism in Australian prostate carcinoma subjects Cancer 92 941–949 Occurrence Handle10.1002/1097-0142(20010815)92:4<941::AID-CNCR1404>3.0.CO;2-P Occurrence Handle1:CAS:528:DC%2BD3MXmvFKnsLY%3D Occurrence Handle11550169
C Chen N Lamharzi NS Weiss et al. (2002) ArticleTitleAndrogen receptor polymorphisms and the incidence of prostate cancer Cancer Epidemiol Biomarkers Prev 11 1033–1040 Occurrence Handle1:CAS:528:DC%2BD38Xos1ekurw%3D Occurrence Handle12376504
ML Santos AS Sarkis IN Nishimoto MA Nagai (2003) ArticleTitleAndrogen receptor CAG repeat polymorphism in prostate cancer from a Brazilian population Cancer Detect Prev 27 321–326 Occurrence Handle10.1016/S0361-090X(03)00106-5 Occurrence Handle14585317
J Xu DA Meyers DA Sterling et al. (2002) ArticleTitleAssociation studies of serum prostate-specific antigen levels and the genetic polymorphisms at the androgen receptor and prostate-specific antigen genes Cancer Epidemiol Biomarkers Prev 11 664–669 Occurrence Handle1:CAS:528:DC%2BD38Xmt1WksLw%3D Occurrence Handle12101115
A Rao BL Chang G Hawkins et al. (2003) ArticleTitleAnalysis of G/A polymorphism in the androgen response element I of the PSA gene and its interactions with the androgen receptor polymorphisms Urology 61 864–869 Occurrence Handle10.1016/S0090-4295(02)02414-7 Occurrence Handle12670590
SD Cramer BL Chang A Rao et al. (2003) ArticleTitleAssociation between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels J Natl Cancer Inst 95 1044–1053 Occurrence Handle1:CAS:528:DC%2BD3sXlsl2kt70%3D Occurrence Handle12865450
Acknowledgements
The authors would like to thank Dr. Noel S. Weiss for his input into the study design and helpful comments on this manuscript. We also wish to acknowledge Cindy Shephard, Keith Thunstedt, and Jasmine Wilkerson for their laboratory work and Dr. David Yanez for his assistance with the matching procedure. The Cardiovascular Health Study <http://www.chs-nhlbi.org> provided all of the subjects and specimens for this project. Cancer incidence data were supplied by the California Cancer Registry, North Carolina Central Cancer Registry, Pennsylvania Bureau of Health Statistics, Maryland Cancer Registry, and Johns Hopkins Training Center for Public Health Research; these institutions specifically disclaim responsibility for any analyses, interpretations, or conclusions expressed herein. This research was supported by NCI grants R03-CA-92706 and T32-CA-09168; NHLBI contracts N01-HC-85079 through N01-HC-85086, N01-HC-35129, and N01 HC-15103; and NIEHS center grant P30-ES07033.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sieh, W., Edwards, K.L., Fitzpatrick, A.L. et al. Genetic Susceptibility to Prostate Cancer: Prostate-specific Antigen and its Interaction with the Androgen Receptor (United States). Cancer Causes Control 17, 187–197 (2006). https://doi.org/10.1007/s10552-005-0454-8
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10552-005-0454-8